Table 5 Association of pRCC histotypes 1 and 2 with classical risk factors and Gal3ST1 expression (Fisher’s exact test).
From: The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma
Parameter | Level | pRCC type 1 | pRCC type 2 | p |
|---|---|---|---|---|
n | 10 | 7 | ||
Sex (%) | m | 8 (80.0) | 5 (71.4) | 1.000 |
w | 2 (20.0) | 2 (28.6) | ||
Age (median [IQR]) | 58.50 [50.75, 66.50] | 73.00 [66.50, 73.50] | 0.157 | |
T Stage (%) | pT1 | 9 (90.0) | 3 (42.9) | 0.026 |
pT2 | 1 (10.0) | 1 (14.3) | ||
pT3/4 | 0 (0.0) | 3 (42.9) | ||
Grading (%) | G1 | 3 (30.0) | 1 (14.3) | 0.369 |
G2 | 7 (70.0) | 4 (57.1) | ||
G3 | 0 (0.0) | 2 (28.6) | ||
N Status (%) | 0 | 10 (100.0) | 6 (85.7) | 0.412 |
1 | 0 (0.0) | 1 (14.3) | ||
M Status (%) | M0 | 10 (100.0) | 4 (57.1) | 0.051 |
M1 | 0 (0.0) | 3 (42.9) | ||
V Status (%) | 0 | 10 (100.0) | 5 (71.4) | 0.154 |
1 | 0 (0.0) | 1 (14.3) | ||
Gal3ST1 (Int*) | 0/0.5 | 5 (50.0) | 3 (42.9) | 0.665 |
1/2 | 4 (40.0) | 2 (28.6) | ||
3 | 1 (10.0) | 2 (28.6) | ||
Sarcomatoid morphology (%) | 0 | 10 (100.0) | 7 (100.0) | 1.000 |
1 | 0 (0.0) | 0 (0.0) | ||
R Status (%) | 0 | 10 (100.0) | 6 (100.0) | 1.000 |
1/2 | 0 (0.0) | 0 (0.0) | ||
L Status (%) | 0 | 10 (100.0) | 6 (85.7) | 0.412 |
1 | 0 (0.0) | 1 (14.3) |
